RGT-61159

N/A

Report date: 2025/06/23 09:09:50
NME

Base Information

Drug NameRGT-61159
Drug Alias NameRGT-61159
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionc-myb expression inhibitors
TargetsTranscriptional activator Myb
Therapy Area/IndicationsSolid tumoursColorectal NeoplasmsBreast Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesRgenta Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRgenta Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursColorectal NeoplasmsBreast Neoplasms +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A